Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder

dc.contributor.authorBilici, Meki
dc.contributor.authorDemir, Fikri
dc.contributor.authorAkin, Alper
dc.contributor.authorTure, Mehmet
dc.contributor.authorBalik, Hasan
dc.contributor.authorKuyumcu, Mahir
dc.date.accessioned2024-04-24T15:59:55Z
dc.date.available2024-04-24T15:59:55Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe aim of this study was to evaluate the feasibility, efficacy and safety of transcatheter closure of patent ductus arteriosus (PDA) with the Occlutech duct occluder (ODO) in children. We reviewed the clinical records of 71 patients who underwent percutaneous closure of PDA with an ODO between September 2014 and August 2016. The Occlutech duct occluder was applied to 71 patients during the study period (September 2014-August 2016), and the results were analyzed in this study. Forty-two of the patients were female and 29 male. The median age was 20.5 months (range, 6-194 months) and median weight was 16 kg (range, 6-68 kg). The PDA was classified as type A in 54 patients (76.1%), type E in 14 (19.7%), type C in 2 (2.8%) and type B in 1 (1.4%) based on the Krichenko classification. A standard ODO device was used for the transcatheter closure procedure in 66 patients and the long-shank ODO device in 5. In the echocardiographic measurement of PDA, the median smallest diameter was 2.7 mm (range, 1.5-7.0 mm), and in the angiographic measurement, the median smallest diameter was 2.5 mm (range, 1.5-6.5 mm). All 71 patients underwent successful PDA closure with the ODO. Angiography following the procedure showed complete closure in 47 patients (66.2%), mild residual shunt in 13 patients (18.3%) and a trivial shunt in 11 patients (15.5%). Color flow Doppler echocardiogpaphy at 24 h post-implantation showed that complete closure was achieved in 65 patients (91.5%), and 6 patients (8.5%) had mild residual shunt. All patients (100%) had complete closure at 30 days of follow-up. The results of this study showed that the Occlutech PDA occluder device is safe and effective in the closure of PDA. As the pulmonary artery side of the device is wider than the aortic side, protrusion toward the aortic side and embolization are prevented, but there is residual shunt in the early period, although this residual shunt disappeared after a few months.en_US
dc.identifier.doi10.1007/s00246-017-1702-x
dc.identifier.endpage1605en_US
dc.identifier.issn0172-0643
dc.identifier.issn1432-1971
dc.identifier.issue8en_US
dc.identifier.pmid28828684
dc.identifier.scopus2-s2.0-85028012111
dc.identifier.scopusqualityQ2
dc.identifier.startpage1598en_US
dc.identifier.urihttps://doi.org/10.1007/s00246-017-1702-x
dc.identifier.urihttps://hdl.handle.net/11468/14308
dc.identifier.volume38en_US
dc.identifier.wosWOS:000415580300010
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofPediatric Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPatent Ductus Arteriosusen_US
dc.subjectChildrenen_US
dc.subjectOcclutech Duct Occluderen_US
dc.titleTranscatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluderen_US
dc.titleTranscatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder
dc.typeArticleen_US

Dosyalar